Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-036846
Filing Date
2007-02-22
Accepted
2007-02-22 13:18:06
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1328086
2 CORPORATE CODE OF BUSINESS CONDUCT AND ETHICS dex141.htm EX-14.1 40832
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5183
4 SECTION 302 CFO CERIFICATION dex312.htm EX-31.2 5172
5 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 2517
  Complete submission text file 0001193125-07-036846.txt   1383130
Mailing Address 8 CLARKE DR CRANBURY NJ 08512
Business Address 8 CLARKE DR CRANBURY NJ 08512 609-409-9010
Valera Pharmaceuticals Inc (Filer) CIK: 0001305409 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51768 | Film No.: 07641283
SIC: 2834 Pharmaceutical Preparations